Bram Piersma, PhD

TitlePostdoc Scholar
InstitutionUniversity of California San Francisco
AddressLocation Required
Varies CA 00000
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Piersma B, Wouters OY, Bank RA. aII-spectrin and ßII-spectrin do not affect TGFß1-induced myofibroblast differentiation. Cell Tissue Res. 2018 May 03. PMID: 29725768.
      View in: PubMed
    2. Piersma B, Wouters OY, de Rond S, Boersema M, Gjaltema RAF, Bank RA. Ascorbic acid promotes a TGFß1-induced myofibroblast phenotype switch. Physiol Rep. 2017 Sep; 5(17). PMID: 28904079.
      View in: PubMed
    3. Piersma B, Bank RA. Keeping fibroblasts in suspense: TAZ-mediated signaling activates a context-dependent profibrotic phenotype. Focus on "TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression". Am J Physiol Cell Physiol. 2017 Mar 01; 312(3):C274-C276. PMID: 28052865.
      View in: PubMed
    4. Piersma B, de Rond S, Werker PM, Boo S, Hinz B, van Beuge MM, Bank RA. YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts. Am J Pathol. 2015 Dec; 185(12):3326-37. PMID: 26458763.
      View in: PubMed
    5. Piersma B, Bank RA, Boersema M. Signaling in Fibrosis: TGF-ß, WNT, and YAP/TAZ Converge. Front Med (Lausanne). 2015; 2:59. PMID: 26389119; PMCID: PMC4558529.